Indian pharmaceutical stocks experienced a downturn following Donald Trump’s renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies like Gland Pharma and Sun Pharma seeing significant declines. Trump’s statement highlighted the intention to incentivize pharmaceutical companies to shift production to the US through tariffs, impacting India’s substantial generic drug exports to the US. Post navigation Trump’s 104% tariffs could cut down China’s GDP growth by 2.4 percentage points, warns Goldman Sachs Trump’s tariffs exacerbate uncertainties! Why RBI cut repo rate by 25 basis points to support GDP growth
